BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Libreros S, Shay AE, Nshimiyimana R, Fichtner D, Martin MJ, Wourms N, Serhan CN. A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution. Front Immunol 2020;11:631319. [PMID: 33643307 DOI: 10.3389/fimmu.2020.631319] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Yasmeen N, Harikrishnan S, Lakhawat SS, Datta M, Sharma PK, Jain A, Khanna R, Jayalakshmi S, Kumar V. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. Biochem Pharmacol 2023;209:115437. [PMID: 36731803 DOI: 10.1016/j.bcp.2023.115437] [Reference Citation Analysis]
2 Kumar V, Yasmeen N, Chaudhary AA, Alawam AS, Al-zharani M, Suliman Basher N, Harikrishnan S, Goud MD, Pandey A, Lakhawat SS, Sharma PK. Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic. Front Mol Biosci 2023;10. [DOI: 10.3389/fmolb.2023.1104577] [Reference Citation Analysis]
3 Lubrano V, Ndreu R, Balzan S. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis. Int J Mol Sci 2023;24. [PMID: 36675152 DOI: 10.3390/ijms24021637] [Reference Citation Analysis]
4 Daly K, O'Sullivan K, O'Sullivan TP. Major structure-activity relationships of resolvins, protectins, maresins and their analogues. Future Med Chem 2022;14:1943-60. [PMID: 36449363 DOI: 10.4155/fmc-2022-0206] [Reference Citation Analysis]
5 Liu C, Fan D, Lei Q, Lu A, He X. Roles of Resolvins in Chronic Inflammatory Response. Int J Mol Sci 2022;23. [PMID: 36499209 DOI: 10.3390/ijms232314883] [Reference Citation Analysis]
6 Deyama S, Kaneda K, Minami M. Resolution of depression: Antidepressant actions of resolvins. Neuroscience Research 2022. [DOI: 10.1016/j.neures.2022.10.006] [Reference Citation Analysis]
7 Yamaguchi A, Botta E, Holinstat M. Eicosanoids in inflammation in the blood and the vessel. Front Pharmacol 2022;13:997403. [PMID: 36238558 DOI: 10.3389/fphar.2022.997403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mahmoudi A, Firouzjaei AA, Darijani F, Navashenaq JG, Taghizadeh E, Darroudi M, Gheibihayat SM. Effect of diabetes on efferocytosis process. Mol Biol Rep 2022. [PMID: 35902446 DOI: 10.1007/s11033-022-07725-2] [Reference Citation Analysis]
9 Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. The complex role of tumor-infiltrating macrophages. Nat Immunol 2022. [PMID: 35879449 DOI: 10.1038/s41590-022-01267-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mázló A, Jenei V, Burai S, Molnár T, Bácsi A, Koncz G. Types of necroinflammation, the effect of cell death modalities on sterile inflammation. Cell Death Dis 2022;13:423. [DOI: 10.1038/s41419-022-04883-w] [Reference Citation Analysis]
11 Kotlyarov S, Kotlyarova A. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis. Int J Mol Sci 2022;23:4808. [PMID: 35563200 DOI: 10.3390/ijms23094808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Artru F, McPhail MJW, Triantafyllou E, Trovato FM. Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids. Front Immunol 2022;13:867261. [PMID: 35432367 DOI: 10.3389/fimmu.2022.867261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Blaudez F, Ivanovski S, Fournier B, Vaquette C. The utilisation of resolvins in medicine and tissue engineering. Acta Biomater 2022;140:116-35. [PMID: 34875358 DOI: 10.1016/j.actbio.2021.11.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Dalli J, Gomez EA, Jouvene CC. Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease. Biomolecules 2022;12:353. [DOI: 10.3390/biom12030353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kotlyarov S, Kotlyarova A. Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease. Int J Mol Sci 2021;22:12803. [PMID: 34884621 DOI: 10.3390/ijms222312803] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Thornton JM, Yin K. Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence. Molecules 2021;26:6970. [PMID: 34834062 DOI: 10.3390/molecules26226970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Sahanic S, Löffler-Ragg J, Tymoszuk P, Hilbe R, Demetz E, Masanetz RK, Theurl M, Holfeld J, Gollmann-Tepeköylü C, Tzankov A, Weiss G, Giera M, Tancevski I. The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza. Front Physiol 2021;12:688946. [PMID: 34366882 DOI: 10.3389/fphys.2021.688946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
18 Decker C, Sadhu S, Fredman G. Pro-Resolving Ligands Orchestrate Phagocytosis. Front Immunol 2021;12:660865. [PMID: 34177900 DOI: 10.3389/fimmu.2021.660865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Tiberi M, Chiurchiù V. Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair. Front Cell Neurosci 2021;15:673549. [PMID: 33981203 DOI: 10.3389/fncel.2021.673549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]